In 2006, Lisa Davis was implanted with a G2 inferior vena cava (IVC) filter made by C.R. Bard. An IVC filter is a spider-like device inserted into the inferior vena cava (the largest vein in the body) designed to catch blood clots that could make their way to the lungs and/or heart, resulting in pulmonary embolism.
The G2 is a retrievable model, which is designed to be inserted only temporarily, and then removed between 29 and 54 days after implantation. If the filter is left in place longer than recommended, the patient is at risk for the filter to migrate, puncture organs and walls of the vein, or fracture.
In June of 2008, when Davis began to experience shortness of breath, heart palpitations, and vertigo, she was diagnosed as having arrhythmia. Upon further investigation, it was found that the IVC filter had fractured, and a shard of the filter lodged into the right ventricle of her heart. She has continued to endure health problems as a result, and is permanently on anticoagulation therapy to control the arrhythmia.
Bard is also the maker of the Recovery filter, which has been linked to at least 27 deaths and hundreds of injuries. According to the manufacturer, the reason behind the Recovery’s high failure rate was due to a defect — the device wasn’t “electropolished,” which means that it had rough “draw marks.” These draw marks allowed too much pressure to build up, and the device would eventually fracture.
Because Bard’s IVC filters have such a high rate of failure, the manufacturer has found itself to be the recipient of many lawsuits seeking compensation for deaths and injuries linked to these IVC filters.
Source: Justia Law